Efficacy of nonsurgical septal reduction therapy in symptomatic patients with obstructive hypertrophic cardiomyopathy and provocable gradients

Am J Cardiol. 2001 Sep 1;88(5):583-6. doi: 10.1016/s0002-9149(01)01748-9.
No abstract available

Publication types

  • Clinical Trial

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Cardiac Catheterization / methods
  • Cardiomyopathy, Hypertrophic / complications
  • Cardiomyopathy, Hypertrophic / diagnosis
  • Cardiomyopathy, Hypertrophic / therapy*
  • Dobutamine
  • Ethanol / administration & dosage*
  • Female
  • Follow-Up Studies
  • Heart Function Tests
  • Heart Septum / drug effects
  • Hemodynamics / physiology
  • Humans
  • Injections, Intralesional
  • Male
  • Middle Aged
  • Probability
  • Severity of Illness Index
  • Treatment Outcome
  • Ventricular Outflow Obstruction / complications
  • Ventricular Outflow Obstruction / diagnosis
  • Ventricular Outflow Obstruction / therapy*

Substances

  • Ethanol
  • Dobutamine